| 000 | 01720 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518043833.0 | ||
| 264 | 0 | _c20191227 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a2191-0251 | ||
| 024 | 7 |
_a10.1515/jpem-2018-0540 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAl-Essa, Mazen | |
| 245 | 0 | 0 |
_aSelective receptor-mediated impairment of growth factor activity in neonatal- and X-linked adrenoleukodystrophy patients. _h[electronic resource] |
| 260 |
_bJournal of pediatric endocrinology & metabolism : JPEM _cJul 2019 |
||
| 300 |
_a733-738 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenoleukodystrophy _xdrug therapy |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xpharmacology |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPeroxisomal Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aPlatelet-Derived Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Platelet-Derived Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 700 | 1 | _aDhaunsi, Gursev S | |
| 773 | 0 |
_tJournal of pediatric endocrinology & metabolism : JPEM _gvol. 32 _gno. 7 _gp. 733-738 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/jpem-2018-0540 _zAvailable from publisher's website |
| 999 |
_c29793998 _d29793998 |
||